Health Conditions

Pancreatitis

Other NamesAcute hemorrhagic pancreatitis

Natural Remedies10

Ingredients24

Table of contents

Other Names

Acute hemorrhagic pancreatitisAcute necrotizing pancreatitisAcute pancreatitisAlcoholic pancreatitisAutoimmune pancreatitisBiliary pancreatitisCalcific pancreatitisCalcifying pancreatitisChronic calcific nonalcoholic pancreatitisChronic calcific pancreatitisChronic calcifying pancreatitisChronic pancreatitisDrug-induced pancreatitisEdematous pancreatitisFibrocalculous pancreatic diabetesGallstone pancreatitisHemorrhagic pancreatitisHemorrhagic-necrotizing pancreatitisHereditary pancreatitisIdiopathic chronic pancreatitisIdiopathic pancreatitisInflammation of the pancreasInterstitial pancreatitisNecrotizing pancreatitisNon-calcific pancreatitisObstructive pancreatitisPancreas inflammationPancreatic apoplexyPancreatic inflammationPancreatitidesRecurrent acute pancreatitisTropical calcific pancreatitisTropical chronic pancreatitisTropical pancreatitis

Synopsis

Pancreatitis: A Nutrition and Natural-Health Reference

Definition and Overview

Pancreatitis is inflammation of the pancreas, which can either be acute (sudden and severe) or chronic (ongoing). It is a potentially serious disorder characterized by inflammation of the pancreas that may cause autodigestion of the organ by its own enzymes. Pancreatitis is the leading cause for gastrointestinal disease-related hospital admissions and is associated with considerable morbidity, mortality, and socioeconomic burden. In the US, acute pancreatitis accounts for an estimated 200,000 to 275,000 hospital admissions annually, making it the leading cause of hospitalization for gastrointestinal disease.

Based on the recognition of common etiological and genetic risk factors, acute and chronic pancreatitis are increasingly regarded as a continuum of the same disease, with a significant overlap of clinical manifestations and phenotypes but distinct morphological and imaging appearances.

The Pancreas: Anatomy and Physiological Role

The pancreas is responsible for insulin production (endocrine pancreas) and the manufacture and secretion of digestive enzymes (exocrine pancreas) leading to carbohydrate, fat, and protein metabolism. Approximately 80% of the gross weight of the pancreas supports exocrine function, and the remaining 20% is involved with endocrine function.

Digestive enzymes are produced within the pancreatic acinar cells, packaged into storage vesicles called zymogens, and then released via the pancreatic ductal cells into the pancreatic duct, where they are secreted into the small intestine to begin the metabolic process. This secretory process is regulated through cytosolic calcium levels in the pancreatic acinar cells.

Clinical Presentation

Acute Pancreatitis

Patients can present with varying degrees of inflammation and disease severity, ranging from self-limiting mild acute pancreatitis to devastating and fatal severe acute pancreatitis. Acute pancreatitis is associated with gastrointestinal symptoms, including diarrhea, pain after eating, anorexia, and unexplained weight loss. In acute pancreatitis, the level of amylase (glycoside hydrolase) is rapidly induced within 4 to 6 h of disease onset, remains high for 3 to 4 days and sensitivity decreases with time from onset. Higher levels of lipase have been found during the onset of acute pancreatitis, and it is more specific and sensitive than amylase for detecting acute pancreatitis because serum level of lipase remains elevated for around 2 weeks before it returns to normal.

Severe forms involve necrosis of the pancreatic tissue, which occurs in 20% of cases, and results in increased complications and mortality. Acute pancreatitis can lead to complications such as necrosis, bacterial superinfection, pseudocyst formation, and chronic fibrosis.

Chronic Pancreatitis

Chronic pancreatitis is defined as a pathological fibro-inflammatory syndrome of the pancreas in individuals with genetic, environmental, and/or other risk factors who develop persistent pathological responses to parenchymal injury or stress. Chronic pancreatitis is a fibroinflammatory disease characterized by the replacement of the pancreatic gland with fibrotic tissue because of repetitive inflammation of the pancreas. It is a dynamic and progressive process, and clinical symptoms and signs crop out as fibrosis develops. The most frequent symptom is abdominal pain in the upper abdomen, and it is often worsened by food intake.

Further complications incurred include both exocrine and endocrine pancreatic insufficiency, pseudocyst formation, bile duct obstruction, and pancreatic cancer. Pancreatitis is frequently associated with diabetes mellitus. Chronic pancreatitis is considered an important risk factor for developing pancreatic cancer, a highly lethal malignancy with few effective therapeutic options.

Pathophysiology and Body Systems Involved

The pathophysiology of acute pancreatitis involves a complex cascade of local pancreatic injury and systemic inflammatory response. The central initiating event is the premature activation of digestive enzymes, particularly trypsin, within pancreatic acinar cells rather than in the intestinal lumen. Under normal physiologic conditions, pancreatic enzymes are synthesized as inactive precursors (zymogens) and activated only upon entering the duodenum. In pancreatitis, however, trypsinogen is inappropriately converted to trypsin within the acinar cells, initiating a proteolytic cascade that activates enzymes such as elastase and phospholipase.

The pathophysiology of acute pancreatitis involves complex interactions between oxidative stress, intracellular calcium dysregulation, and immune cell activation. Reactive oxygen and nitrogen species contribute to acinar cell injury by driving apoptosis or necrosis and amplifying inflammatory cascades. Leukocytes, including neutrophils, monocytes, macrophages, lymphocytes, and platelets, then infiltrate pancreatic tissue and produce cytokines and chemokines, thereby exacerbating tissue damage.

Pancreatic stellate cells play a central role in fibrosis by modulating the deposition of the extracellular matrix and promoting persistent inflammation. Clinical and experimental observations have provided compelling evidence that premature intrapancreatic activation of digestive proteases is critical in pancreatitis onset. However, disease course and severity are mostly governed by inflammatory cells that drive local and systemic immune responses.

The systemic inflammatory response syndrome (SIRS) can also develop, leading to the involvement of remote organ systems beyond the pancreas, including the lungs, kidneys, and cardiovascular system in severe cases.

Contributing and Associated Factors

Gallstones and Biliary Disease

Causes of acute pancreatitis can easily be identified in 75–85% of patients. The main causes of acute, recurrent acute, and chronic pancreatitis are gallstone migration and alcohol abuse. Genetic predisposition to cholelithiasis (OR = 1.365, P = 1.307E-19) was associated with increased risk of acute pancreatitis in Mendelian randomization analysis.

Alcohol Consumption

Excessive alcohol consumption is a well-established etiological factor for both acute pancreatitis (~20%) and chronic pancreatitis (40–70%). Alcohol-related pancreatitis usually manifests in patients with over five years of ongoing, substantial alcohol use (~4–5 drinks daily) and only rarely occurs from isolated binge drinking. Alcohol may sensitize the pancreas to damage by external and environmental factors such as genetics, high-fat diet, cigarette use, and infectious agents, yet relatively few people with alcohol use syndrome will develop pancreatitis (less than 5%).

Alcohol-induced pancreatitis likely results from alcohol causing increased, viscous secretions that block small pancreatic ducts and by premature activation of digestive and lysosomal enzymes within acinar cells. Alcohol exposure contributes to the initiation and progression of pancreatitis and amplifies the association between genetic risk factors and chronic pancreatitis in a dose-dependent manner.

Tobacco Smoking

Cigarette smoking is recognized as an independent risk factor that may contribute to both acute and chronic pancreatitis. Smoking was shown to increase the risk of chronic pancreatitis by two- to three-fold even among non-alcohol drinkers or light drinkers, accentuating its role as a risk factor independent of alcohol consumption. A meta-analysis of prospective studies showed that smoking is associated with a 49% and 93% increased risk of acute and chronic pancreatitis, respectively. Smoking promotes the progression from acute pancreatitis to recurrent acute pancreatitis or chronic pancreatitis and accelerates the development of alcohol-induced pancreatitis.

Metabolic and Dietary Factors

Contributing factors include rising rates of obesity, metabolic syndrome, and associated hypertriglyceridemia, all of which are recognized risk factors for pancreatitis. Recent population-based and cohort studies have found that hypertriglyceridemia has been identified as a risk factor for acute pancreatitis — even when plasma levels are only mildly elevated. In multivariable Mendelian randomization analysis, cholelithiasis, triglycerides, and the waist-to-hip ratio remained significant predictors.

Genetic Factors

Tobacco smoke conveys a greater risk than immoderate alcohol consumption for the development of chronic pancreatitis. Hereditary pancreatitis, in its autosomal dominant form, is associated with mutations in the cationic trypsinogen gene (PRSS1), whereas a number of germline variations in other genes have been found to represent risk factors for chronic as well as acute pancreatitis. Environmental exposures such as malnutrition and dietary cyanogens, combined with genetic susceptibility, particularly SPINK1 mutations, contribute to the pathogenesis of tropical pancreatitis.

Other Contributing Factors

Trauma, whether blunt abdominal, penetrating, or postoperative, can directly injure the pancreas and initiate inflammatory cascades. Ischemic injury due to vascular compromise or systemic hypotension can also lead to pancreatic inflammation. Vasculitides such as systemic lupus erythematosus and polyarteritis nodosa are additional rare causes. The Toxic-Metabolic, Idiopathic, Genetic, Autoimmune, Recurrent and Severe Acute Pancreatitis, Obstructive (TIGAR-O) classification system categorizes known causes and factors that contribute to chronic pancreatitis.

Nutritional Consequences of Pancreatitis

Many factors contribute to malnutrition in acute pancreatitis, especially abnormal metabolism and catabolism related to inflammation. Chronic pancreatitis precipitates complex malnutrition through synergistic mechanisms: exocrine pancreatic insufficiency-driven maldigestion, duodenal or pancreatobiliary strictures limiting nutrient flow, cholestasis impairing micelle formation, alcohol-related anorexia, and pain-induced hypophagia.

Deficiencies in micronutrients — vitamin B12, folic acid, vitamin A, D, and E, zinc, selenium, and iron — are well documented in patients with pancreatic exocrine insufficiency, and are diverse in presentation, with some studies reporting biochemical deficiencies and case reports documenting clinical manifestations including night blindness. It is common to detect decreased levels of vitamin A, vitamin D, and vitamin E (fat-soluble vitamins), as well as retinol transport protein, prealbumin, osteocalcin, and essential minerals such as magnesium, zinc, and selenium in these patients.

A study of 301 patients with chronic pancreatitis and 266 controls showed that patients with chronic pancreatitis had significantly lower concentrations of vitamins A, D, and E. Mineral deficiencies of magnesium, zinc, copper, and selenium have been reported, and although supplementation of these is likely to be of benefit in chronic pancreatitis, intervention studies are warranted.

Screening for vitamin and mineral deficiencies — vitamins A, D, E, K, B12, folate, magnesium, selenium, zinc, and iron — is necessary at the time of diagnosis and annually thereafter, depending on the patient's clinical condition.

Dietary Approaches Discussed in the Literature

The Paradigm Shift: From "Pancreatic Rest" to Early Nutrition

The nutritional management of acute pancreatitis patients has widely changed over time. The "pancreatic rest" was the cornerstone of the old paradigm, and nutritional support was not even included in acute pancreatitis management. Traditional management was based on intestinal rest, with or without complete parenteral feeding.

Evidence-based data have underlined the superiority of early oral or enteral feeding with significantly decreased multiple-organ failure, systemic infections, surgery need, and mortality rate. The concept of "pancreatic rest" is not evidence-based. There is emerging evidence that supports the use of oral or enteral nutrition to improve nutrition status and to reduce local and systemic inflammation, complications, and death.

High-quality evidence along with society guidelines have recommended the use of enteral nutrition over parenteral nutrition in patients with pancreatitis. The use of enteral nutrition has been demonstrated to decrease mortality and infectious complications compared with parenteral nutrition. The ideal timing of initiating enteral nutrition is not clear; however, early nutrition (within 48 hours) appears to be safe and tolerated.

In patients with predicted mild acute pancreatitis, oral feeding should be started as soon as possible regardless of serum lipase and amylase levels. In mild disease, patients are generally able to initiate a solid oral diet and do not require specialized nutrition care such as enteral or parenteral nutrition.

Dietary Fat and Macronutrient Considerations in Chronic Pancreatitis

Nutritional therapy in chronic pancreatitis should be multifactorial and based on abstinence from alcohol and nicotine, and diet modification. International guidelines no longer recommend severe dietary fat restriction; on the contrary, a physiological diet is recommended, but with adequate replacement of pancreatic enzymes. In cases of intolerance to physiological nutrition, a low-fat diet with oral nutritional supplements is recommended to replenish energy and nutrients.

In patients with chronic pancreatitis, there is no need for dietary fat restriction unless symptoms of steatorrhea cannot be controlled with adequate doses of pancreatic enzymes; diets very high in fiber should also be avoided. This last recommendation is related to the fact that fibers can absorb pancreatic enzymes (including those administered for replacement) and can lead to inadequate substitution treatment.

Specific Nutrients, Antioxidants, and Natural Compounds

Antioxidant Vitamins (Vitamins A, C, and E)

Scientific Evidence: Oxidative stress plays a major role in the pathogenesis of pancreatitis. Antioxidant therapy in the form of high-dose vitamins has been used for the treatment of severe acute pancreatitis with equivocal results. A study by Bansal et al. showed that vitamin-based antioxidant therapy (vitamins A, E, and C administered together) had no significant beneficial effect on organ dysfunction or on clinical outcomes in severe acute pancreatitis during hospital stay.

A major development in chronic pancreatitis research was the first double-blind, placebo-controlled randomized trial that showed effectiveness of oral antioxidant supplementation (organic selenium, ascorbic acid, alpha-tocopherol, beta-carotene, and methionine) in relieving pain in patients with chronic pancreatitis. However, this finding was not uniformly replicated. A subsequent investigation — the double-blind, randomized controlled ANTICIPATE trial (70 patients with chronic pancreatitis) — found that antioxidant therapy did not significantly reduce pain or improve quality of life. After 6 months, pain scores in the placebo group were reduced by 1.97 from baseline, and by 2.33 in the antioxidant group, but the difference between groups was not statistically significant.

The present studies indicate that insufficient clinical data support using antioxidants alone or in combination with conventional therapy in the management of acute pancreatitis. Further double-blind, randomized, placebo-controlled clinical trials with a larger sample size need to be conducted.

Vitamin E (Alpha-Tocopherol)

Scientific Evidence: Data from experimental models and one small-scale clinical trial suggesting antioxidant and anti-inflammatory effects of alpha-tocopherol in acute pancreatitis look encouraging, though the evidence remains preliminary.

Vitamin D

Scientific Evidence: Vitamin D deficiency or insufficiency may have a negative impact on acute pancreatitis evolution, but there is still no clinical evidence that restoring vitamin D levels before acute pancreatitis onset could lead to better outcomes. Nevertheless, the beneficial effect of vitamin D supplementation was documented due to its antioxidant properties in various pathologies.

Selenium

Scientific Evidence: A study by Kuklinski et al. showed the beneficial effect of an adjuvant antioxidant therapy with selenium and D-alpha-tocopherol in 90 patients with necrotizing or mild acute pancreatitis, reporting that the average lethality rate of 34% fell to 1.1%. This study represents proposed vital benefits of antioxidant therapy. However, this was a single, non-replicated study and must be interpreted with caution given the limitations of its design.

Omega-3 Fatty Acids

Scientific Evidence: Accumulating evidence has suggested that omega-3 fatty acids can alter cytokine production, modulate inflammatory and immunological response, and thus may be expected to lower the rates of infectious complications and shorten hospital stay in intensive care or on regular medical wards. Anti-inflammatory and immunomodulatory effects of omega-3 fatty acids may provide an important therapeutic option for patients with acute pancreatitis.

Results from randomized controlled trials assessing the effects of omega-3 fatty acids administered by parenteral or enteral nutrition in acute pancreatitis patients were inconsistent. A meta-analysis reported that enteral nutrition supplemented with omega-3 fatty acids had no beneficial effects on infectious complications, mortality, or length of hospital stay in acute pancreatitis patients, though the sample size of this meta-analysis was fairly small and the analysis excluded studies of parenteral nutrition. According to the current evidence, the role of omega-3 fatty acid treatment in acute pancreatitis patients remains unclear.

Glutamine

Scientific Evidence: Due to the immunosuppressive and inflammatory nature of the disease, immunonutrients like glutamine and omega-3 fatty acids have been added to parenteral or enteral formulas to modulate immune functions, suppress the hyper inflammatory responses, and reestablish tissue and organ homeostasis in clinical practice. Evidence from systematic reviews on glutamine in severe acute pancreatitis has been examined, though results across trials have been mixed, and larger well-designed trials are still needed to define the appropriate role and route of glutamine supplementation.

Probiotics

Scientific Evidence: The role of immunonutrition and probiotics in modulating inflammatory response and gut dysbiosis during acute pancreatitis has been extensively studied; however, there are no significant data supporting their routine use in clinical practice. Systematic analysis showed that probiotics did not significantly affect the pancreatic infection rate, total infections, or operation rate in severe acute pancreatitis. The results of multicenter randomized clinical trials have been contradictory. Further studies that are better designed are needed to better define the safety and the efficacy of probiotics in acute pancreatitis management.

Curcumin (from Turmeric, Curcuma longa)

Traditional Use: Turmeric has been used for centuries in Ayurvedic and traditional Chinese medicine as an anti-inflammatory agent for a broad range of digestive complaints.

Scientific Evidence: Inflammation plays an important role in the initiation and development of severe acute pancreatitis. Curcumin exerts potent anti-inflammatory effects in many diseases, including acute pancreatitis, though the specific molecular mechanisms are not fully clear. Pre-treatment with curcumin in animal models reduced the concentrations of interleukin-6 and tumor necrosis factor alpha in serum and ascites, as well as ascites volume and amylase levels, demonstrating mechanistic anti-inflammatory activity in rodent models. Importantly, clinical human trial evidence for curcumin specifically in pancreatitis is lacking; existing data are limited to animal and cell-based studies. In a rat model, curcuminoids attenuated the severity of pancreatitis. Evidence strength is therefore classified as preliminary/preclinical only.

Milk Thistle (Silybum marianum) and Silymarin

Traditional Use: For more than 2000 years, Silybum marianum (milk thistle) has been used for treating different complications such as jaundice, hepatitis, and cancers. Its primary traditional application has been hepatoprotective — supporting liver and biliary function — rather than pancreas-specific use.

Scientific Evidence: Silymarin (25 mg/kg, 50 mg/kg, and 100 mg/kg) weakened the severity of acute pancreatitis in mice due to inhibition of p38 mitogen-activated protein kinase (MAPKs). In animal models, milk thistle (silymarin) supplementation has been shown to decrease the severity of pancreatitis in mice given chemicals (cerulein) to induce pancreatitis. No clinical human trials specifically testing silymarin for pancreatitis have been identified in the peer-reviewed literature to date. Evidence is limited to animal and in-vitro models and must be characterized as preliminary.

Berberine

Traditional Use: Berberine is a protoberberine isoquinoline alkaloid isolated from many plant species, such as Berberis aquifolium or Coptis chinensis, which has been extensively used for gut infections and diarrhea for centuries as a part of Ayurvedic and traditional Chinese medicine.

Scientific Evidence: Berberine has been shown in preclinical research to inhibit inflammatory mediators and attenuate acute pancreatitis through deactivation of JNK signaling pathways. Berberine has various pharmacological effects including lowering blood glucose, lowering blood lipids, improving insulin sensitivity, and anti-inflammatory and anti-oxidant effects. Evidence in the context of pancreatitis specifically is confined to cell and animal models; no adequately powered human trials in pancreatitis have been identified.

Lifestyle Factors Discussed in Authoritative Sources

Alcohol Cessation

In a study of alcohol abstinence in patients with acute alcoholic pancreatitis, the recurrence rate was significantly lower in patients who were repeatedly instructed to abstain from alcohol after discharge than in those who were instructed only once at time of discharge. In principle, patients with alcoholic pancreatitis should be instructed to refrain from alcohol, meaning permanent abstinence.

Alcohol cessation results in a lower rate of exocrine insufficiency, pseudocysts, and acute pancreatitis episodes. Alcohol cessation in chronic pancreatitis reduces exocrine insufficiency, abdominal pain, and local complications.

Smoking Cessation

Abstinence from smoking may also prevent progression of chronic pancreatitis; therefore, guidelines recommend providing guidance on smoking cessation. In a cross-sectional study of 870 patients with chronic pancreatitis, smoking cessation reduced the relapse frequency of acute pancreatitis episodes. A possible explanation is that alcohol-related chronic pancreatitis arises due to a modifiable risk factor, making pancreatic damage potentially partially reversible with alcohol abstinence and improved nutrition. Many of these patients are also smokers, representing another modifiable risk factor, where smoking cessation may further slow disease progression.

Body Weight and Metabolic Health

Higher body mass index (OR = 1.335, P = 3.077E-04) and greater waist circumference (OR = 1.466, P = 0.011) were associated with increased risk of acute pancreatitis in Mendelian randomization analysis. The effect of obesity traits on acute pancreatitis was attenuated after correcting for cholelithiasis, suggesting that some of the obesity-related risk may be mediated through gallstone formation.

Physical Activity and Multidisciplinary Support

A structured, evidence-based strategy integrating pancreatic enzyme replacement therapy, macronutrient engineering, micronutrient repletion, and metabolic surveillance is essential to mitigate nutrition-related morbidity, enhance long-term outcomes, and optimize quality of life in chronic pancreatitis. Interprofessional collaboration — engaging specialists in gastroenterology, pain management, endocrinology, nutrition, and rehabilitation — is emphasized to optimize patient care and improve patient outcomes.

Dietary Pattern Modifications

Nutritional therapy in chronic pancreatitis should be multifactorial and based on abstinence from alcohol and nicotine, and diet modification. Medical treatment of chronic pancreatitis involves controlling pain, addressing malnutrition via the treatment of vitamin and mineral deficiencies, recognizing the risk of osteoporosis, and administering appropriate pancreatic enzyme supplementation and diabetic agents.

If patients show signs of deficiency, inadequate intake, or have prolonged malabsorption, clinicians should test for nutritional deficiencies such as vitamin A, D, E, K, B12, and other micronutrients including iron, zinc, selenium, and copper. Serum values should be rechecked three months after replacement.

Summary of Evidence Strength

Strong evidence (supported by multiple RCTs, meta-analyses, and guidelines): Early enteral/oral nutrition over parenteral nutrition or "pancreatic rest" in acute pancreatitis; alcohol cessation reducing recurrence and exocrine insufficiency in chronic pancreatitis; smoking cessation to reduce relapse frequency; monitoring and repletion of fat-soluble vitamins (A, D, E, K) and minerals (zinc, selenium, iron, magnesium) in chronic pancreatitis with exocrine insufficiency.
Moderate/mixed evidence (RCTs exist but results are inconsistent): Antioxidant vitamin combinations (selenium, vitamins A/C/E/E, beta-carotene, methionine) for pain in chronic pancreatitis — some trials positive, others negative; omega-3 fatty acids in acute pancreatitis (immunomodulatory plausibility, but clinical outcomes unclear).
Preliminary/preclinical evidence only (animal models and in-vitro studies; no adequate human trials): Curcumin (anti-inflammatory in rodent models); silymarin/milk thistle (severity reduction in cerulein-induced pancreatitis in mice); berberine (anti-inflammatory via JNK pathway in cell models).
Uncertain or insufficient evidence: Probiotics in severe acute pancreatitis (contradictory RCT results, no net benefit demonstrated in meta-analyses); glutamine supplementation (mechanistically plausible for gut barrier support, but clinical data mixed).

References

Natural Remedies

Remedy 1

Low-Fat, Small-Meal Eating Pattern: A low-fat diet reduces the demand placed on the pancreas to produce digestive enzymes, easing inflammation and discomfort. Eat small, frequent meals throughout the day — focusing on steamed vegetables, fruits, and lean proteins — rather than large meals, which strain the organ. Avoid fried, processed foods, and saturated fats that can trigger flare-ups.

Remedy 2

Turmeric (Curcumin): Curcumin, the active compound in turmeric, has powerful anti-inflammatory properties that may reduce pancreatic inflammation. Add fresh or powdered turmeric to warm water, broths, or food daily, or take 500–1,000 mg of curcumin extract with meals. Consistent use in traditional and natural-health practice supports its role as a key herbal ally for the pancreas.

Remedy 3

Ginger Tea: Ginger is well-known for its digestive and anti-nausea effects, helping to reduce abdominal discomfort and inflammation associated with pancreatitis. Brew a tea from fresh sliced or grated ginger root and sip it 2–3 times per day, or chew small slices of fresh ginger to ease symptoms. It is one of the most widely recommended herbal remedies in natural pancreatitis care.

Remedy 4

Licorice Root: Licorice root (Glycyrrhiza glabra) has outstanding anti-inflammatory actions that can help reduce swelling and ease the pain of pancreatitis, and has a long history of use in traditional Chinese medicine for pancreatic disorders. It can be taken as a tea or a standardized extract (DGL form is gentler on the body). Use with care and avoid long-term high-dose use, as it can affect blood pressure.

Remedy 5

Dandelion Root Tea: Dandelion root is a particularly good herb for pancreatitis because it supports the digestion of fats by stimulating bile production, taking burden off an inflamed pancreas. Brew dried dandelion root as a tea and drink 1–2 cups daily. Its gentle bitter compounds have been used in herbal traditions to support both liver and pancreatic health.

Remedy 6

Medicinal Mushrooms (Reishi, Shiitake, Maitake): Reishi mushrooms contain powerful anti-inflammatory agents and have an analgesic effect that can improve pancreatitis symptoms; their terpenoid compounds decrease COX-2 expression and inhibit prostaglandin E2 production, easing pain and inflammation. Shiitake and Maitake mushrooms similarly contain compounds that relieve inflammation in the pancreas and help protect it. Add these mushrooms to soups and meals regularly, or use them in supplement form.

Remedy 7

Antioxidant-Rich Foods (Berries, Leafy Greens, Sweet Potatoes): Eating more fruits and vegetables rich in antioxidants — such as blueberries, spinach, sweet potatoes, and apples — helps combat oxidative stress in the pancreas, which is closely linked to inflammation and disease progression. A daily handful of blueberries in the morning has been specifically noted as supportive, and supplemental antioxidants like vitamin C, vitamin E, and selenium have shown promise in small clinical trials. Make these the cornerstone of every meal.

Remedy 8

Hydration with Herbal Teas and Water: Staying well-hydrated supports digestion and helps the body clear inflammatory byproducts. Sip on water, clear broths, or gentle herbal teas like chamomile, peppermint, or ginger throughout the day, which soothe the digestive tract and promote better hydration. Avoid sugary drinks, alcohol, and caffeinated beverages that can irritate the pancreas.

Remedy 9

Stress Reduction Practices (Meditation, Deep Breathing): Stress can worsen inflammation and increase the likelihood of pancreatitis flare-ups, making regular stress management a vital part of natural care. Practice daily mindfulness meditation, gentle deep-breathing exercises, or yoga to lower the body's inflammatory stress response. Even 10–15 minutes of calm, focused breathing per day can help regulate the nervous system and support digestive function.

Remedy 10

Moderate, Gentle Exercise: Regular moderate exercise can improve overall digestion, reduce systemic inflammation, and help maintain a healthy weight, all of which are important for pancreatic health. Opt for low-impact activities such as walking, swimming, or gentle yoga rather than intense exertion, which can stress the body during recovery. Aim for 20–30 minutes of gentle movement most days of the week, gradually building as tolerance improves.

Ingredients

These ingredients are often used in alternative medicine to support pancreatitis.

amylaseScientific
Elevated serum amylase is a classical diagnostic biomarker for acute pancreatitis, with levels exceeding three times the upper limit of normal forming part of the revised Atlanta Classification diagnostic criteria. In chronic pancreatitis, amylase output is reduced due to exocrine pancreatic insufficiency, and amylase is a key component of PERT used to restore digestion.
berberineScientific
Berberine (BBR), a plant alkaloid from traditional Chinese medicine herbs, has demonstrated anti-inflammatory activity against both acute and chronic pancreatitis in preclinical models. It inhibits JNK, NF-κB, and MAPK signaling, reducing serum amylase, lipase, TNF-α, IL-1β, and IL-6 in cerulein- and L-arginine-induced mouse models. A 2020 study showed berberine attenuates chronic pancreatitis fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling.
beta-caroteneScientific
Beta-carotene has been included in antioxidant combination regimens studied in multiple RCTs for chronic pancreatitis pain relief. A systematic review found that the antioxidant cocktail (selenium, beta-carotene, vitamin C, vitamin E, methionine) significantly reduced pain in chronic pancreatitis patients. A 2024 rat study also demonstrated beta-carotene alone reduced oxidative stress markers and inflammatory gene expression in L-arginine-induced acute pancreatitis.
bovine pancreasScientific
Chronic pancreatitis leads to exocrine pancreatic insufficiency (EPI), for which pancreatic enzyme preparations (pancreatin), including bovine-derived forms, have been used clinically since the late 1800s. Multiple RCTs and a 2017 meta-analysis (17 studies, 511 patients) confirm that PERT significantly improves fat and nitrogen absorption versus placebo in CP-related EPI. A 1-year prospective multicenter study (294 patients) found gastrointestinal symptoms and recurrent pain were significantly reduced (P<0.001). Bovine preparations are a recognized alternative to porcine, though with lower lipase activity.
curcuminScientific
Multiple preclinical studies in rat and mouse models show curcumin inhibits NF-κB and AP-1 activation, reducing pancreatic inflammation in both ethanol and non-ethanol pancreatitis models. A small randomized pilot trial in tropical pancreatitis patients demonstrated significant reductions in oxidative stress markers (MDA) and increases in glutathione with 500 mg curcumin plus piperine for 6 weeks. More recent work shows curcumin ameliorates cerulein-induced chronic pancreatitis fibrosis via Nrf2/HO-1 signaling in mouse models.
DHA (docosahexaenoic acid)Scientific
DHA, a long-chain omega-3 fatty acid, has been shown in a rat cerulein model to inhibit NF-κB and PKCδ activation, reduce IL-6 expression, and limit oxidative damage in the pancreas, suggesting potential to prevent or ameliorate pancreatitis. Omega-3 fatty acid supplementation including DHA has been studied in clinical nutrition trials in acute pancreatitis.
gardeniaScientific
Gardenia jasminoides has been directly tested in a cerulein-induced acute pancreatitis mouse model, demonstrating protective effects including reduced pancreatic weight/body weight ratio, lower serum amylase and lipase, and suppressed pro-inflammatory mediators TNF-α, IL-1β, and IL-6. Geniposide also protects pancreatic beta-cells from oxidative stress damage in diabetes models.
gardenia jasminoidesScientific
Gardenia jasminoides was shown to protect against cerulein-induced acute pancreatitis in mice (C57BL/6), significantly reducing pancreatic edema, amylase/lipase levels, and lung injury in a dose-dependent manner. Geniposide has also been identified as a promising therapeutic for acute pancreatitis by ameliorating acinar cell injury and oxidative stress. Evidence is preclinical.
L-glutamineScientific
L-glutamine is an immunonutrient with antioxidative and gut-barrier-preserving properties that has been evaluated in clinical trials for acute pancreatitis. Glutamine-supplemented total parenteral nutrition reduced blood mononuclear cell IL-8 release in severe acute pancreatitis in a clinical study. Multiple nutrition reviews and trials support intravenous glutamine's benefits in AP patients receiving total parenteral nutrition.
lipaseScientific
Chronic pancreatitis destroys pancreatic acinar cells, reducing lipase output and causing exocrine pancreatic insufficiency (EPI). Lipase-containing pancreatic enzyme replacement therapy (PERT) is the established treatment. Multiple RCTs and meta-analyses confirm that PERT significantly improves fat absorption and reduces steatorrhea in chronic pancreatitis patients. Recommended dosing is 25,000–40,000 lipase units per meal using enteric-coated microspheres.
MCT (medium chain triglycerides)Scientific
In chronic pancreatitis with exocrine insufficiency and steatorrhea, MCTs are a clinically used dietary intervention because their absorption does not require pancreatic lipase or bile salts. A small study in 8 chronic pancreatitis patients found MCT consumption reduced postprandial pain by minimizing CCK stimulation. MCT oil is recommended by clinical gastroenterology guidance when standard pancreatic enzyme replacement is inadequate.
melatoninScientific
Melatonin, produced endogenously from L-tryptophan, has receptors in pancreatic tissue and has demonstrated protective effects against acute pancreatitis in numerous experimental studies and clinical observations. It reduces ROS/RNS, preserves antioxidant enzyme activity, decreases TNF-α, improves pancreatic blood flow, and reduces apoptosis and necrosis. Clinical reviews indicate potential for prevention of post-ERCP pancreatitis.
milk thistleScientific
Milk thistle's active constituent silymarin has shown anti-inflammatory effects against pancreatitis in preclinical models, attenuating cerulein-induced acute pancreatitis in mice by inhibiting p38 MAPK signaling and reducing oxidative stress, cytokines TNF-α and IL-6, and tissue damage. Small-scale clinical studies have reported symptom improvements in chronic pancreatitis patients. Traditional use includes recommendation for alcohol-related chronic pancreatitis.
NAC (N-acetyl cysteine)Scientific
NAC has been studied as an antioxidant therapy in both acute and post-ERCP pancreatitis due to its glutathione-precursor and anti-inflammatory properties. Animal studies show it improves pancreatic microvascular perfusion and reduces necrosis in acute necrotizing pancreatitis. A 2007 randomized double-blind placebo-controlled trial (n=43) of IV antioxidants including NAC in severe AP found no significant benefit on organ dysfunction, showing mixed clinical results.
omega-3 fatty acidsScientific
Omega-3 fatty acids have been studied as immunonutritional supplements in acute pancreatitis management through multiple clinical trials. They reduce pro-inflammatory cytokine production and have been shown to attenuate systemic inflammatory sequelae in experimental pancreatitis. Multiple clinical nutrition reviews and trials support their inclusion in enteral/parenteral nutrition formulations for severe acute pancreatitis.
quercetinScientific
Quercetin, a natural flavonoid, demonstrates antioxidant, anti-inflammatory, and immunomodulatory properties relevant to acute pancreatitis (AP) in multiple preclinical studies. In cerulein-induced AP mouse models, quercetin pretreatment reduced pancreatic edema, inflammatory cell infiltration, acinar necrosis, TNF-α expression, and myeloperoxidase activity. A 2025 comprehensive review in Frontiers in Pharmacology highlights its multifaceted therapeutic potential for AP, though clinical validation is still needed.
resveratrolScientific
Resveratrol, a natural polyphenol, has been reviewed as a potential medical drug for acute pancreatitis due to its anti-inflammatory and antioxidant mechanisms. In animal studies it reduces TNF-α, IL-6, NF-κB activation, serum amylase, and pancreatic microvascular damage. A 2021 comprehensive review concluded it may attenuate AP and its complications through cytokine suppression.
rhubarb rootScientific
Multiple meta-analyses of RCTs support rhubarb as an adjunct in severe acute pancreatitis (SAP), reducing hospitalization duration, abdominal pain, inflammatory markers, and mortality when added to standard care or early enteral nutrition. A 2020 meta-analysis of 11 RCTs (724 patients) showed significant improvements across all clinical parameters.
seleniumScientific
Selenium deficiency has been identified in patients with chronic pancreatitis, and selenium-containing antioxidant combinations have been studied in multiple RCTs for chronic pancreatitis pain relief. A double-blind placebo-controlled RCT (n=36) using a combination including organic selenium showed significant pain reduction and quality of life improvement in chronic pancreatitis patients. The clinical evidence for selenium as part of antioxidant cocktails (with vitamins C, E, beta-carotene, methionine) is supported by systematic reviews.
silymarinScientific
Silymarin has been investigated for pancreatic protection in the context of its anti-inflammatory and antioxidant properties. Its use in pathological conditions of the pancreas is documented in review literature. It is noted as potentially relevant to pancreatitis via oxidative stress reduction and cytokine suppression, but dedicated large-scale human RCTs for pancreatitis specifically are limited.
SPMs (specialized pro-resolving mediators)Scientific
SPMs have demonstrated efficacy in preclinical chronic pancreatitis models. Pancreatic inflammation involves macrophage and neutrophil infiltration processes that SPMs actively counter. Pancreatitis is listed in validated SPM efficacy compilations based on the Serhan Cold Spring Harbor Perspectives reference.
stigmasterolScientific
Stigmasterol protected against acute pancreatitis in a sodium taurocholate (STC)-induced mouse model by targeting the ERK1 signaling pathway, reducing lipase, amylase, acinar cell necrosis, and systemic inflammation. Evidence is preclinical only.
vitamin CScientific
Vitamin C (ascorbic acid) has been studied both as monotherapy and in antioxidant combinations for pancreatitis. Multiple RCTs of combined antioxidants (including ascorbic acid, beta-carotene, vitamin E, selenium, methionine) showed pain reduction in chronic pancreatitis. An open observational study found vitamin C 0.5 g/day plus vitamin E for 12 months abolished pain in 44% of 70 chronic pancreatitis patients. Clinical evidence is mainly as part of combination antioxidant regimens.
vitamin EScientific
Vitamin E (alpha-tocopherol) has been evaluated in combination antioxidant regimens for chronic pancreatitis pain management. Multiple placebo-controlled RCTs of combination antioxidants including vitamin E showed significant pain reduction in chronic pancreatitis. A meta-analysis found statistically significant pain benefit in RCTs using methionine-containing combinations that invariably included vitamin E.